Management Team
 |
Navneet Puri, Ph.D.
President & CEO
InnoPharma, Inc. was founded by Dr. Navneet Puri. Dr. Puri is a pharmacist by educational training and has M.S. and Ph.D. degrees in Pharmaceutical Sciences. He has particular expertise in parenteral product development and injectable microparticulate drug delivery systems.
Prior to founding InnoPharma, Inc. Dr. Puri has had several years of work experience in major US pharmaceutical industry, primarily including Baxter Healthcare Corp., and Amgen Inc. His professional experience was primarily in parenteral pharmaceutical formulations, process R&D and microparticulate based sustained drug delivery systems for parenteral administration. He was also involved in Business Development and Project Management. He was credited with establishing a novel technology platform for blending drugs for parenteral administration while working at Baxter. He has published numerous research and review articles in eminent scientific journals, authored patents and made presentations at national and international scientific conferences.
|
|
 |
Sriram J. Ramanathan, MS, MBA
Chief Operating Officer
Mr. Ramanathan is a co-founder in InnoPharma, Inc. He is a pharmacist by educational training and has an MS degree in Pharmaceutical Sciences. Prior to joining InnoPharma, Inc., Mr. Ramanathan has had several years of experience in major US pharmaceutical industry, including Roche Vitamins Inc, Inhale Therapeutics (now Nektar Therapeutics), Alpharma and Cardinal Health. His professional experience and expertise ranges from R&D, process development, regulatory affairs and operations, as well as management of projects through development, regulatory filing and commercialization.
|
|
 |
Satish Pejaver, Ph.D.
Chief Scientific Officer
Dr Pejaver joined InnoPharma, Inc. as its CSO after approx. 23 years of R&D experience in industry, majority of which was at Baxter Healthcare Corp.
Dr Pejaver played a key role in growing the generic injectable business unit of Baxter, and was responsible for developing various generic injectable products, as well as few selected NCEs. While at Baxter, he led a team of 80+ scientists, in groups including analytical R&D, stability R&D, formulation and process R&D for injectable as well as inhalation anesthetics. In addition to R&D he also worked closely with project management and regulatory affairs groups, in successful development, regulatory filing and commercial launch of several products, most significant of which was generic propofol injectable emulsion.
At InnoPharma, Inc., Dr Pejaver provides operational as well as strategic R&D leadership. He leads the entire R&D team of InnoPharma, Inc., as well as its regulatory operations & affairs and project management groups.
|
|
 |
John C Deighan, CPA
Chief Financial Officer
Mr Deighan is responsible for all aspects of InnoPharma’s finance, accounting, planning, treasury and administrative functions.
Prior to joining InnoPharma, Mr. Deighan was chief financial officer of Eagle Pharmaceuticals, a hospital specialty company focused on reformulating and improving injectable drugs. Mr. Deighan established the financial and administrative functions of Eagle, and participated in the negotiation of licensing and financing deals for the Company, in addition to his involvement in various strategic and operational decisions of the company. Previously, Mr. Deighan held the position of corporate controller at Orchid Cellmark, a DNA testing services laboratory and of divisional controller at Alpharma, a diversified global pharmaceutical company. Mr. Deighan received a Bachelor of Science in business administration from the State University of New York at Oswego, and is a certified public accountant.
|
|
| The key management is supported by a team of scientists, including 10 PhDs |
|
Appreciation
Innopharma is proud to announce that we were awarded a grant under NJ Business Employment and Incentive Program (BEIP), designed for companies that are poised to create jobs in the state of New Jersey.
Additional information on the BEIP grants can be found at www.njeda.com/beip.
|
